Raghu Vemuganti - Publications

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
MCAO, brain trauma

113/168 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Mehta SL, Arruri V, Vemuganti R. Role of transcription factors, noncoding RNAs, epitranscriptomics, and epigenetics in post-ischemic neuroinflammation. Journal of Neurochemistry. PMID 38279529 DOI: 10.1111/jnc.16055  0.408
2023 Mehta SL, Chelluboina B, Morris-Blanco KC, Bathula S, Jeong S, Arruri V, Davis CK, Vemuganti R. Post-stroke brain can be protected by modulating the lncRNA FosDT. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X231212378. PMID 37933735 DOI: 10.1177/0271678X231212378  0.415
2023 Chelluboina B, Vemuganti R. Gene Silencing in the Brain with siRNA to Promote Long-Term Post-Stroke Recovery. Methods in Molecular Biology (Clifton, N.J.). 2616: 419-425. PMID 36715950 DOI: 10.1007/978-1-0716-2926-0_29  0.329
2023 Chokkalla AK, Jeong S, Subramanian S, Vemuganti R. Immunomodulatory role of glycoRNAs in the brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X231151995. PMID 36644904 DOI: 10.1177/0271678X231151995  0.317
2022 Mehta SL, Chokkalla AK, Bathula S, Arruri V, Chelluboina B, Vemuganti R. CDR1as regulates α-synuclein-mediated ischemic brain damage by controlling miR-7 availability. Molecular Therapy. Nucleic Acids. 31: 57-67. PMID 36618263 DOI: 10.1016/j.omtn.2022.11.022  0.332
2022 Arruri V, Chokkalla AK, Jeong S, Chelluboina B, Mehta SL, Veeravalli KK, Vemuganti R. MMP-12 knockdown prevents secondary brain damage after ischemic stroke in mice. Neurochemistry International. 161: 105432. PMID 36252818 DOI: 10.1016/j.neuint.2022.105432  0.342
2022 Morris-Blanco KC, Chokkalla AK, Arruri V, Jeong S, Probelsky SM, Vemuganti R. Epigenetic mechanisms and potential therapeutic targets in stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X221116192. PMID 35854641 DOI: 10.1177/0271678X221116192  0.348
2022 Chokkalla AK, Pajdzik K, Dou X, Dai Q, Mehta SL, Arruri V, Vemuganti R. Dysregulation of the Epitranscriptomic Mark mA in Ischemic Stroke. Translational Stroke Research. PMID 35737185 DOI: 10.1007/s12975-022-01056-x  0.34
2022 Chelluboina B, Kieft K, Breister A, Anantharaman K, Vemuganti R. Gut virome dysbiosis following focal cerebral ischemia in mice. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X221107702. PMID 35702025 DOI: 10.1177/0271678X221107702  0.32
2022 Rayasam A, Kijak JA, Kissel L, Choi YH, Kim T, Hsu M, Joshi D, Laaker CJ, Cismaru P, Lindstedt A, Kovacs K, Vemuganti R, Chiu SY, Priyathilaka TT, Sandor M, et al. CXCL13 expressed on inflamed cerebral blood vessels recruit IL-21 producing T cells to damage neurons following stroke. Journal of Neuroinflammation. 19: 125. PMID 35624463 DOI: 10.1186/s12974-022-02490-2  0.375
2022 Morris-Blanco KC, Chokkalla AK, Kim T, Bhatula S, Bertogliat MJ, Gaillard AB, Vemuganti R. High-Dose Vitamin C Prevents Secondary Brain Damage After Stroke via Epigenetic Reprogramming of Neuroprotective Genes. Translational Stroke Research. PMID 35306630 DOI: 10.1007/s12975-022-01007-6  0.37
2022 Arruri V, Vemuganti R. Role of autophagy and transcriptome regulation in acute brain injury. Experimental Neurology. 352: 114032. PMID 35259350 DOI: 10.1016/j.expneurol.2022.114032  0.32
2021 Lopez MS, Morris-Blanco KC, Ly N, Maves C, Dempsey RJ, Vemuganti R. MicroRNA miR-21 Decreases Post-stroke Brain Damage in Rodents. Translational Stroke Research. PMID 34796453 DOI: 10.1007/s12975-021-00952-y  0.314
2021 Chelluboina B, Chokkalla AK, Mehta SL, Morris-Blanco KC, Bathula S, Sankar S, Park JS, Vemuganti R. Tenascin-C induction exacerbates post-stroke brain damage. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211056392. PMID 34689646 DOI: 10.1177/0271678X211056392  0.393
2021 Chokkalla AK, Mehta SL, Vemuganti R. Epitranscriptomic Modifications Modulate Normal and Pathological Functions in CNS. Translational Stroke Research. PMID 34224107 DOI: 10.1007/s12975-021-00927-z  0.763
2021 Mehta SL, Chokkalla AK, Kim T, Bathula S, Chelluboina B, Morris-Blanco KC, Holmes A, Banerjee A, Chauhan A, Lee J, Venna VR, McCullough LD, Vemuganti R. Long Noncoding RNA Fos Downstream Transcript Is Developmentally Dispensable but Vital for Shaping the Poststroke Functional Outcome. Stroke. STROKEAHA120033547. PMID 33940958 DOI: 10.1161/STROKEAHA.120.033547  0.776
2020 Chelluboina B, Vemuganti R. Therapeutic Potential of Nutraceuticals to Protect Brain after Stroke. Neurochemistry International. 104908. PMID 33220386 DOI: 10.1016/j.neuint.2020.104908  0.325
2020 Banerjee A, Chokkalla AK, Shi JJ, Lee J, Venna VR, Vemuganti R, McCullough LD. Microarray Profiling Reveals Distinct Circulating miRNAs in Aged Male and Female Mice Subjected to Post-stroke Social Isolation. Neuromolecular Medicine. PMID 33074466 DOI: 10.1007/s12017-020-08622-2  0.753
2020 Chokkalla AK, Mehta SL, Vemuganti R. Epitranscriptomic regulation by mA RNA methylation in brain development and diseases. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20960033. PMID 32967524 DOI: 10.1177/0271678X20960033  0.766
2020 Kim T, Chokkalla AK, Vemuganti R. Deletion of ubiquitin ligase Nedd4l exacerbates ischemic brain damage. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20943804. PMID 32703111 DOI: 10.1177/0271678X20943804  0.781
2020 Metzger JM, Lopez MS, Schmidt JK, Murphy ME, Vemuganti R, Emborg ME. Effects of Cardiac Sympathetic Neurodegeneration and PPAR Activation on Rhesus Macaque Whole Blood miRNA and mRNA Expression Profiles. Biomed Research International. 2020: 9426204. PMID 32462037 DOI: 10.1155/2020/9426204  0.336
2020 Morris-Blanco KC, Chokkalla AK, Bertogliat MJ, Vemuganti R. TET3 regulates DNA hydroxymethylation of neuroprotective genes following focal ischemia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20912965. PMID 32380888 DOI: 10.1177/0271678X20912965  0.787
2020 Famakin BM, Vemuganti R. Toll-Like Receptor 4 Signaling in Focal Cerebral Ischemia: a Focus on the Neurovascular Unit. Molecular Neurobiology. 57: 2690-2701. PMID 32306272 DOI: 10.1007/S12035-020-01906-5  0.413
2020 Mehta SL, Dempsey RJ, Vemuganti R. Role of Circular RNAs in Brain Development and CNS Diseases. Progress in Neurobiology. 101746. PMID 31931031 DOI: 10.1016/J.Pneurobio.2020.101746  0.448
2020 Nalamolu KR, Challa SR, Mohandass A, Mussman JP, Ilahi SB, Bedadala MR, Klopfenstein JD, Pinson DM, Wang DZ, Kalyanasundaram R, Vemuganti R, Veeravalli KK. ShRNA‐mediated gene silencing of t‐PA prevents BBB disruption and elevation of MMP‐12 after ischemic stroke The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05550  0.437
2019 Bertogliat MJ, Morris-Blanco KC, Vemuganti R. Epigenetic mechanisms of neurodegenerative diseases and acute brain injury. Neurochemistry International. 104642. PMID 31838024 DOI: 10.1016/J.Neuint.2019.104642  0.397
2019 Chokkalla AK, Mehta SL, Kim T, Chelluboina B, Kim J, Vemuganti R. Transient Focal Ischemia Significantly Alters the mA Epitranscriptomic Tagging of RNAs in the Brain. Stroke. STROKEAHA119026433. PMID 31436138 DOI: 10.1161/Strokeaha.119.026433  0.797
2019 Morris-Blanco KC, Kim T, Lopez MS, Bertogliat MJ, Chelluboina B, Vemuganti R. Induction of DNA Hydroxymethylation Protects the Brain After Stroke. Stroke. STROKEAHA119025665. PMID 31327315 DOI: 10.1161/STROKEAHA.119.025665  0.418
2019 Kim T, Chelluboina B, Chokkalla AK, Vemuganti R. Age and sex differences in the pathophysiology of acute CNS injury. Neurochemistry International. PMID 30654116 DOI: 10.1016/j.neuint.2019.01.012  0.756
2019 Vemuganti R, Chelluboina B, Mehta SL, Kim T, Chokkalla AK, Bathula S, Park JS. Chronic kidney disease exacerbates post-stroke brain damage Ibro Reports. 6: S228. DOI: 10.1016/J.Ibror.2019.07.711  0.77
2018 Kim T, Mehta SL, Morris-Blanco KC, Chokkalla AK, Chelluboina B, Lopez M, Sullivan R, Kim HT, Cook TD, Kim JY, Kim H, Kim C, Vemuganti R. The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein. Science Signaling. 11. PMID 30538177 DOI: 10.1126/scisignal.aat4285  0.755
2018 Morris-Blanco KC, Kim T, Bertogliat MJ, Mehta SL, Chokkalla AK, Vemuganti R. Inhibition of the Epigenetic Regulator REST Ameliorates Ischemic Brain Injury. Molecular Neurobiology. PMID 30039336 DOI: 10.1007/s12035-018-1254-y  0.793
2018 Nalamolu KR, Smith NJ, Chelluboina B, Klopfenstein JD, Pinson DM, Wang DZ, Vemuganti R, Veeravalli KK. Corrigendum to "Prevention of the Severity of Post-ischemic Inflammation and Brain Damage by Simultaneous Knockdown of Toll-like Receptors 2 and 4" [Neuroscience 373 (2018) 82-91]. Neuroscience. PMID 29879419 DOI: 10.1016/J.Neuroscience.2018.05.038  0.404
2018 Verma R, Ritzel RM, Harris NM, Lee J, Kim T, Pandi G, Vemuganti R, McCullough LD. Inhibition of miR-141-3p Ameliorates the Negative Effects of Poststroke Social Isolation in Aged Mice. Stroke. PMID 29866755 DOI: 10.1161/Strokeaha.118.020627  0.358
2018 Kim J, Kang SW, Mallilankaraman K, Baik SH, Lim JC, Balaganapathy P, She DT, Lok KZ, Fann DY, Thambiayah U, Tang SC, Stranahan AM, Dheen ST, Gelderblom M, Seet RC, ... ... Vemuganti R, et al. Transcriptome analysis reveals intermittent fasting-induced genetic changes in ischemic stroke. Human Molecular Genetics. PMID 29688516 DOI: 10.1093/Hmg/Ddy138  0.398
2018 Lopez MS, Vemuganti R. Modeling Transient Focal Ischemic Stroke in Rodents by Intraluminal Filament Method of Middle Cerebral Artery Occlusion. Methods in Molecular Biology (Clifton, N.J.). 1717: 101-113. PMID 29468587 DOI: 10.1007/978-1-4939-7526-6_9  0.44
2018 Kim J, Kang SW, Mallilankaraman K, Baik SH, Lim JC, Balaganapathy P, She DT, Lok KZ, Fann DY, Thambiayah U, Tang SC, Stranahan AM, Dheen ST, Gelderblom M, Seet RC, ... ... Vemuganti R, et al. Transcriptome Analysis Reveals Intermittent Fasting-Induced Genetic Changes in Ischemic Stroke. Human Molecular Genetics. PMID 29447348 DOI: 10.1093/Hmg/Ddy057  0.39
2017 Li G, Morris-Blanco KC, Lopez MS, Yang T, Zhao H, Vemuganti R, Luo Y. Impact of microRNAs on ischemic stroke: From pre- to post-disease. Progress in Neurobiology. PMID 28842356 DOI: 10.1016/j.pneurobio.2017.08.002  0.34
2017 Mehta SL, Pandi G, Vemuganti R. Circular RNA Expression Profiles Alter Significantly in Mouse Brain After Transient Focal Ischemia. Stroke. PMID 28701578 DOI: 10.1161/STROKEAHA.117.017469  0.356
2017 Silva VR, Secolin R, Vemuganti R, Lopes-Cendes I, Hazell AS. Acute liver failure is associated with altered cerebral expression profiles of long non-coding RNAs. Neuroscience Letters. PMID 28648459 DOI: 10.1016/J.Neulet.2017.06.038  0.683
2017 Kim T, Vemuganti R. Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17694186. PMID 28273718 DOI: 10.1177/0271678X17694186  0.385
2017 Chandran R, Mehta SL, Vemuganti R. Non-coding RNAs and neuroprotection after acute CNS injuries. Neurochemistry International. PMID 28131900 DOI: 10.1016/J.Neuint.2017.01.015  0.407
2017 Demuth HU, Dijkhuizen RM, Farr TD, Gelderblom M, Horsburgh K, Iadecola C, Mcleod DD, Michalski D, Murphy TH, Orbe J, Otte WM, Petzold GC, Plesnila N, Reiser G, Reymann KG, ... ... Vemuganti R, et al. Recent progress in translational research on neurovascular and neurodegenerative disorders. Restorative Neurology and Neuroscience. PMID 28059802 DOI: 10.3233/Rnn-160690  0.347
2017 Dharap A, Vemuganti R. Noncoding RNAs and Stroke Primer On Cerebrovascular Diseases. 276-279. DOI: 10.1016/B978-0-12-803058-5.00057-6  0.477
2016 Balog J, Mehta SL, Vemuganti R. Mitochondrial fission and fusion in secondary brain damage after CNS insults. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27677674 DOI: 10.1177/0271678X16671528  0.323
2016 Kim T, Mehta SL, Kaimal B, Lyons K, Dempsey RJ, Vemuganti R. Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 7055-65. PMID 27358461 DOI: 10.1523/Jneurosci.1241-16.2016  0.379
2016 Lopez MS, Dempsey RJ, Vemuganti R. Resveratrol preconditioning induces cerebral ischemic tolerance but has minimal effect on cerebral microRNA profiles. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27323784 DOI: 10.1177/0271678X16656202  0.485
2015 Mehta SL, Kim T, Vemuganti R. Long Noncoding RNA FosDT Promotes Ischemic Brain Injury by Interacting with REST-Associated Chromatin-Modifying Proteins. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 16443-9. PMID 26674869 DOI: 10.1523/Jneurosci.2943-15.2015  0.515
2015 Chelluboina B, Klopfenstein JD, Pinson DM, Wang DZ, Vemuganti R, Veeravalli KK. Matrix Metalloproteinase-12 Induces Blood-Brain Barrier Damage After Focal Cerebral Ischemia. Stroke; a Journal of Cerebral Circulation. PMID 26534974 DOI: 10.1161/Strokeaha.115.011031  0.38
2015 Lopez M, Dempsey RJ, Vemuganti R. Resveratrol Neuroprotection in Stroke and Traumatic CNS injury. Neurochemistry International. PMID 26277384 DOI: 10.1016/J.Neuint.2015.08.009  0.41
2015 Dharap A, Pokrzywa C, Murali S, Kaimal B, Vemuganti R. Mutual induction of transcription factor PPARγ and microRNAs miR-145 and miR-329. Journal of Neurochemistry. PMID 26119485 DOI: 10.1111/Jnc.13220  0.353
2015 Vemuganti R, Silva VR, Mehta SL, Hazell AS. Erratum to: Acute liver failure-induced hepatic encephalopathy is associated with changes in microRNA expression profiles in cerebral cortex of the mouse. Metabolic Brain Disease. 30: 247. PMID 25537182 DOI: 10.1007/S11011-014-9644-Y  0.635
2015 Kim TH, Vemuganti R. Effect of sex and age interactions on functional outcome after stroke. Cns Neuroscience & Therapeutics. 21: 327-36. PMID 25404174 DOI: 10.1111/Cns.12346  0.418
2015 Vemuganti R, Zhao H. Mechanisms and therapies for acute CNS insults. Metabolic Brain Disease. 30: 353. PMID 24997133 DOI: 10.1007/S11011-014-9585-5  0.476
2014 Nakka VP, Prakash-Babu P, Vemuganti R. Crosstalk Between Endoplasmic Reticulum Stress, Oxidative Stress, and Autophagy: Potential Therapeutic Targets for Acute CNS Injuries. Molecular Neurobiology. PMID 25482050 DOI: 10.1007/S12035-014-9029-6  0.321
2014 Vemuganti R. Non-coding RNAs in CNS disorders--the long and short of it. Neurochemistry International. 77: 1. PMID 25257042 DOI: 10.1016/J.Neuint.2014.08.004  0.457
2014 Vemuganti R, Hazell AS. Mechanisms of hepatic encephalopathy and thiamine deficiency. Metabolic Brain Disease. 29: 889-90. PMID 24972879 DOI: 10.1007/S11011-014-9579-3  0.632
2014 Mehta SL, Dharap A, Vemuganti R. Expression of transcribed ultraconserved regions of genome in rat cerebral cortex. Neurochemistry International. 77: 86-93. PMID 24953281 DOI: 10.1016/J.Neuint.2014.06.006  0.377
2014 Vemuganti R, Silva VR, Mehta SL, Hazell AS. Acute liver failure-induced hepatic encephalopathy is associated with changes in microRNA expression profiles in cerebral cortex of the rat. Metabolic Brain Disease. 29: 891-9. PMID 24861182 DOI: 10.1007/S11011-014-9545-0  0.639
2013 Dharap A, Pokrzywa C, Murali S, Pandi G, Vemuganti R. MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene. Plos One. 8: e79467. PMID 24265774 DOI: 10.1371/Journal.Pone.0079467  0.342
2013 Dharap A, Pokrzywa C, Vemuganti R. Increased binding of stroke-induced long non-coding RNAs to the transcriptional corepressors Sin3A and coREST. Asn Neuro. 5: 283-9. PMID 24063527 DOI: 10.1042/An20130029  0.47
2013 Vemuganti R. All's well that transcribes well: non-coding RNAs and post-stroke brain damage. Neurochemistry International. 63: 438-49. PMID 23954844 DOI: 10.1016/J.Neuint.2013.07.014  0.482
2013 Pandi G, Nakka VP, Dharap A, Roopra A, Vemuganti R. MicroRNA miR-29c down-regulation leading to de-repression of its target DNA methyltransferase 3a promotes ischemic brain damage. Plos One. 8: e58039. PMID 23516428 DOI: 10.1371/Journal.Pone.0058039  0.405
2013 Wesley UV, Vemuganti R, Ayvaci ER, Dempsey RJ. Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling. Brain Research. 1496: 1-9. PMID 23246924 DOI: 10.1016/J.Brainres.2012.12.008  0.407
2012 Dharap A, Nakka VP, Vemuganti R. Effect of focal ischemia on long noncoding RNAs. Stroke; a Journal of Cerebral Circulation. 43: 2800-2. PMID 22949471 DOI: 10.1161/Strokeaha.112.669465  0.472
2011 Nakka VP, Lang BT, Lenschow DJ, Zhang DE, Dempsey RJ, Vemuganti R. Increased cerebral protein ISGylation after focal ischemia is neuroprotective. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 2375-84. PMID 21847135 DOI: 10.1038/Jcbfm.2011.103  0.407
2011 Dharap A, Nakka VP, Vemuganti R. Altered expression of PIWI RNA in the rat brain after transient focal ischemia. Stroke; a Journal of Cerebral Circulation. 42: 1105-9. PMID 21311060 DOI: 10.1161/Strokeaha.110.598391  0.478
2011 Tureyen K, Bowen K, Liang J, Dempsey RJ, Vemuganti R. Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia. Journal of Neurochemistry. 116: 499-507. PMID 21133923 DOI: 10.1111/J.1471-4159.2010.07127.X  0.407
2010 Vemuganti R. The MicroRNAs and Stroke: No Need to be Coded to be Counted. Translational Stroke Research. 1: 158-60. PMID 20725586 DOI: 10.1007/S12975-010-0030-8  0.453
2010 Dempsey RJ, Vemuganti R, Varghese T, Hermann BP. A review of carotid atherosclerosis and vascular cognitive decline: a new understanding of the keys to symptomology. Neurosurgery. 67: 484-93; discussion 4. PMID 20644437 DOI: 10.1227/01.Neu.0000371730.11404.36  0.361
2010 Dharap A, Vemuganti R. Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. Journal of Neurochemistry. 113: 1685-91. PMID 20402966 DOI: 10.1111/J.1471-4159.2010.06735.X  0.363
2010 Vemuganti R, Dempsey R, Tureyen K, Salamat S, Hermann B. P142 CAROTID PLAQUES FROM SYMPTOMATIC STROKE PATIENTS SHOW INDUCTION OF GENES THAT ARE RELATED TO PROLIFERATION, ANGIOGENESIS AND NEURODEGENERATIVE DISORDERS Atherosclerosis Supplements. 11: 46. DOI: 10.1016/S1567-5688(10)70209-9  0.388
2009 Yan YP, Lang BT, Vemuganti R, Dempsey RJ. Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia. Neurochemistry International. 55: 826-32. PMID 19686792 DOI: 10.1016/J.Neuint.2009.08.007  0.441
2009 Yan YP, Lang BT, Vemuganti R, Dempsey RJ. Galectin-3 mediates post-ischemic tissue remodeling. Brain Research. 1288: 116-24. PMID 19573520 DOI: 10.1016/J.Brainres.2009.06.073  0.471
2009 Yan YP, Lang BT, Vemuganti R, Dempsey RJ. Persistent migration of neuroblasts from the subventricular zone to the injured striatum mediated by osteopontin following intracerebral hemorrhage. Journal of Neurochemistry. 109: 1624-35. PMID 19457159 DOI: 10.1111/J.1471-4159.2009.06059.X  0.319
2009 Jensen MB, Chacon MR, Sattin JA, Levine RL, Vemuganti R. Potential biomarkers for the diagnosis of stroke. Expert Review of Cardiovascular Therapy. 7: 389-93. PMID 19379063 DOI: 10.1586/Erc.09.9  0.365
2009 Liu YP, Lang BT, Baskaya MK, Dempsey RJ, Vemuganti R. The potential of neural stem cells to repair stroke-induced brain damage. Acta Neuropathologica. 117: 469-80. PMID 19283395 DOI: 10.1007/S00401-009-0516-1  0.435
2009 Dressler J, Vemuganti R. Apoptosis and gene expression after TBI. Legal Medicine (Tokyo, Japan). 11: S54-5. PMID 19282216 DOI: 10.1016/J.Legalmed.2009.02.024  0.385
2009 Dharap A, Bowen K, Place R, Li LC, Vemuganti R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 675-87. PMID 19142192 DOI: 10.1038/Jcbfm.2008.157  0.412
2008 Vemuganti R. Therapeutic Potential of PPARγ Activation in Stroke. Ppar Research. 2008: 461981. PMID 21909480 DOI: 10.1155/2008/461981  0.465
2008 Yi JH, Park SW, Brooks N, Lang BT, Vemuganti R. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Research. 1244: 164-72. PMID 18948087 DOI: 10.1016/J.Brainres.2008.09.074  0.582
2008 Tureyen K, Brooks N, Bowen K, Svaren J, Vemuganti R. Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. Journal of Neurochemistry. 105: 1313-24. PMID 18208539 DOI: 10.1111/J.1471-4159.2008.05233.X  0.494
2008 Kapadia R, Yi JH, Vemuganti R. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Frontiers in Bioscience : a Journal and Virtual Library. 13: 1813-26. PMID 17981670 DOI: 10.2741/2802  0.6
2008 Dhodda VK, Sailor K, Dempsey RJ, Vemuganti RLR. Novel mediators of ischemic preconditioning induced neuroprotection Journal of Neurochemistry. 81: 108-111. DOI: 10.1046/j.1471-4159.81.s1.42_3.x  0.304
2007 Park SW, Yan YP, Satriotomo I, Vemuganti R, Dempsey RJ. Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions. Journal of Neurosurgery. 107: 593-9. PMID 17886560 DOI: 10.3171/Jns-07/09/0593  0.32
2007 Yi JH, Park SW, Kapadia R, Vemuganti R. Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochemistry International. 50: 1014-27. PMID 17532542 DOI: 10.1016/J.Neuint.2007.04.019  0.645
2007 Wiltrout C, Lang B, Yan Y, Dempsey RJ, Vemuganti R. Repairing brain after stroke: a review on post-ischemic neurogenesis. Neurochemistry International. 50: 1028-41. PMID 17531349 DOI: 10.1016/J.Neuint.2007.04.011  0.47
2007 Tureyen K, Kapadia R, Bowen KK, Satriotomo I, Liang J, Feinstein DL, Vemuganti R. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. Journal of Neurochemistry. 101: 41-56. PMID 17394460 DOI: 10.1111/J.1471-4159.2006.04376.X  0.448
2007 Yan YP, Sailor KA, Lang BT, Park SW, Vemuganti R, Dempsey RJ. Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 1213-24. PMID 17191078 DOI: 10.1038/Sj.Jcbfm.9600432  0.441
2007 Park SW, Yi JH, Miranpuri G, Satriotomo I, Bowen K, Resnick DK, Vemuganti R. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. The Journal of Pharmacology and Experimental Therapeutics. 320: 1002-12. PMID 17167171 DOI: 10.1124/Jpet.106.113472  0.555
2007 Resnick DK, Vemuganti R, Miranpuri GS, Miletic G, Miletic V. Spinal Dorsal Horn Gene Expression Following Loose Ligation of the Rat Sciatic Nerve Annals of Neurosciences. 14: 24-29. DOI: 10.5214/146  0.306
2006 Satriotomo I, Bowen KK, Vemuganti R. JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. Journal of Neurochemistry. 98: 1353-68. PMID 16923154 DOI: 10.1111/J.1471-4159.2006.04051.X  0.443
2006 Kapadia R, Tureyen K, Bowen KK, Kalluri H, Johnson PF, Vemuganti R. Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia. Journal of Neurochemistry. 98: 1718-31. PMID 16899075 DOI: 10.1111/J.1471-4159.2006.04056.X  0.428
2006 Yan YP, Sailor KA, Vemuganti R, Dempsey RJ. Insulin-like growth factor-1 is an endogenous mediator of focal ischemia-induced neural progenitor proliferation. The European Journal of Neuroscience. 24: 45-54. PMID 16882007 DOI: 10.1111/J.1460-9568.2006.04872.X  0.402
2006 Bowen KK, Naylor M, Vemuganti R. Prevention of inflammation is a mechanism of preconditioning-induced neuroprotection against focal cerebral ischemia. Neurochemistry International. 49: 127-35. PMID 16759752 DOI: 10.1016/J.Neuint.2006.02.011  0.453
2006 Türeyen K, Vemuganti R, Salamat MS, Dempsey RJ. Increased angiogenesis and angiogenic gene expression in carotid artery plaques from symptomatic stroke patients. Neurosurgery. 58: 971-7; discussion 97. PMID 16639334 DOI: 10.1227/01.Neu.0000210246.61817.Fe  0.396
2006 Vemuganti R, Dempsey RJ. Increased expression of genes that control ionic homeostasis, second messenger signaling and metabolism in the carotid plaques from patients with symptomatic stroke. Journal of Neurochemistry. 97: 92-6. PMID 16635256 DOI: 10.1111/J.1471-4159.2005.03516.X  0.433
2006 Vemuganti R, Kalluri H, Yi JH, Bowen KK, Hazell AS. Gene expression changes in thalamus and inferior colliculus associated with inflammation, cellular stress, metabolism and structural damage in thiamine deficiency. The European Journal of Neuroscience. 23: 1172-88. PMID 16553781 DOI: 10.1111/J.1460-9568.2006.04651.X  0.73
2006 Schmitt C, Miranpuri GS, Dhodda VK, Isaacson J, Vemuganti R, Resnick DK. Changes in spinal cord injury-induced gene expression in rat are strain-dependent. The Spine Journal : Official Journal of the North American Spine Society. 6: 113-9. PMID 16517380 DOI: 10.1016/J.Spinee.2005.05.379  0.303
2006 Dempsey R, Vemuganti R, Hermann B. Mo-W4:5 Increased expression of neurodegenerative disease related genes in the carotid plaques from symptomatic stroke patients Atherosclerosis Supplements. 7: 18. DOI: 10.1016/S1567-5688(06)80048-6  0.403
2006 Vemuganti R, Carson MJ. Cerebral inflammation: How homeland defense is handled in the CNS Neurochemistry International. 49: 105. DOI: 10.1016/J.Neuint.2006.04.001  0.355
2005 Türeyen K, Vemuganti R, Bowen KK, Sailor KA, Dempsey RJ. EGF and FGF-2 infusion increases post-ischemic neural progenitor cell proliferation in the adult rat brain. Neurosurgery. 57: 1254-63; discussion . PMID 16331174 DOI: 10.1227/01.Neu.0000186040.96929.8A  0.382
2005 Naylor M, Bowen KK, Sailor KA, Dempsey RJ, Vemuganti R. Preconditioning-induced ischemic tolerance stimulates growth factor expression and neurogenesis in adult rat hippocampus. Neurochemistry International. 47: 565-72. PMID 16154234 DOI: 10.1016/J.Neuint.2005.07.003  0.415
2005 Vemuganti R. Decreased expression of vesicular GABA transporter, but not vesicular glutamate, acetylcholine and monoamine transporters in rat brain following focal ischemia. Neurochemistry International. 47: 136-42. PMID 15936116 DOI: 10.1016/J.Neuint.2005.04.015  0.34
2005 Türeyen K, Vemuganti R, Sailor KA, Dempsey RJ. Ideal suture diameter is critical for consistent middle cerebral artery occlusion in mice. Neurosurgery. 56: 196-200; discussion . PMID 15799811 DOI: 10.1227/01.Neu.0000144490.92966.59  0.334
2005 Vemuganti R, Dempsey RJ. Carotid atherosclerotic plaques from symptomatic stroke patients share the molecular fingerprints to develop in a neoplastic fashion: a microarray analysis study. Neuroscience. 131: 359-74. PMID 15708479 DOI: 10.1016/J.Neuroscience.2004.08.058  0.44
2005 Tureyen K, Sundaresan R, Bowen K, Vemuganti R. PPAR-γ agonist rosiglitazone decreases focal cerebral ischemia-induced inflammation and brain damage in adult mice Journal of Cerebral Blood Flow & Metabolism. 25: S94-S94. DOI: 10.1038/Sj.Jcbfm.9591524.0094  0.439
2004 Türeyen K, Vemuganti R, Sailor KA, Bowen KK, Dempsey RJ. Transient focal cerebral ischemia-induced neurogenesis in the dentate gyrus of the adult mouse. Journal of Neurosurgery. 101: 799-805. PMID 15540918 DOI: 10.3171/Jns.2004.101.5.0799  0.389
2004 Türeyen K, Vemuganti R, Sailor KA, Dempsey RJ. Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. Journal of Neuroscience Methods. 139: 203-7. PMID 15488233 DOI: 10.1016/J.Jneumeth.2004.04.029  0.352
2004 Resnick DK, Schmitt C, Miranpuri GS, Dhodda VK, Isaacson J, Vemuganti R. Molecular evidence of repair and plasticity following spinal cord injury. Neuroreport. 15: 837-9. PMID 15073526 DOI: 10.1097/00001756-200404090-00020  0.313
2004 Dhodda VK, Sailor KA, Bowen KK, Vemuganti R. Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. Journal of Neurochemistry. 89: 73-89. PMID 15030391 DOI: 10.1111/J.1471-4159.2004.02316.X  0.495
2004 Vemuganti R, Dempsey RJ, Bowen KK. Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat. Stroke; a Journal of Cerebral Circulation. 35: 179-84. PMID 14657453 DOI: 10.1161/01.Str.0000106479.53235.3E  0.422
2003 Dempsey RJ, Sailor KA, Bowen KK, Türeyen K, Vemuganti R. Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF. Journal of Neurochemistry. 87: 586-97. PMID 14535942 DOI: 10.1046/J.1471-4159.2003.02022.X  0.377
Low-probability matches (unlikely to be authored by this person)
2021 Boltze J, Aronowski JA, Badaut J, Buckwalter MS, Caleo M, Chopp M, Dave KR, Didwischus N, Dijkhuizen RM, Doeppner TR, Dreier JP, Fouad K, Gelderblom M, Gertz K, Golubczyk D, ... ... Vemuganti R, et al. New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases. Frontiers in Aging Neuroscience. 13: 623751. PMID 33584250 DOI: 10.3389/fnagi.2021.623751  0.299
2020 Alrfaei BM, Clark P, Vemuganti R, Kuo JS. MicroRNA miR-100 Decreases Glioblastoma Growth by Targeting SMARCA5 and ErbB3 in Tumor-Initiating Cells. Technology in Cancer Research & Treatment. 19: 1533033820960748. PMID 32945237 DOI: 10.1177/1533033820960748  0.298
2013 Alrfaei BM, Vemuganti R, Kuo JS. Abstract LB-245: MicroRNA-100 targets silencing mediator for retinoid receptors (SMRT), reduces proliferation, and improves survival in glioblastoma. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-245  0.295
2013 Alrfaei BM, Vemuganti R, Kuo JS. microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models. Plos One. 8: e80865. PMID 24244722 DOI: 10.1371/Journal.Pone.0080865  0.293
2019 Vemuganti R, Sohrabji F. Age and sex differences in post-ischemic outcome and therapy. Neurochemistry International. 104472. PMID 31128131 DOI: 10.1016/J.Neuint.2019.104472  0.291
2017 Chelluboina B, Nalamolu KR, Klopfenstein JD, Pinson DM, Wang DZ, Vemuganti R, Veeravalli KK. MMP-12, a Promising Therapeutic Target for Neurological Diseases. Molecular Neurobiology. PMID 28155200 DOI: 10.1007/S12035-017-0418-5  0.288
2020 Nalamolu KR, Challa SR, Fornal CA, Martin RC, Olson EA, Ujjainwala AL, Klopfenstein JD, Pinson DM, Wang DZ, Kalyanasundaram R, Vemuganti R, Veeravalli KK. MMP‐12 knockdown during acute and chronic phases promotes post‐stroke neurological recovery The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.06135  0.285
2022 Chokkalla AK, Jeong S, Mehta SL, Davis CK, Morris-Blanco KC, Bathula S, Qureshi SS, Vemuganti R. Cerebroprotective Role of -Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) After Experimental Stroke. Stroke. PMID 36321453 DOI: 10.1161/STROKEAHA.122.040401  0.283
2023 Jeong S, Chokkalla AK, Davis CK, Vemuganti R. Post-stroke depression: epigenetic and epitranscriptomic modifications and their interplay with gut microbiota. Molecular Psychiatry. PMID 37188778 DOI: 10.1038/s41380-023-02099-8  0.281
2016 Al-Rfaei B, Vemuganti R, Kuo J. GENT-35. MicroRNA miR100 INHIBITS GLIOBLASTOMA GROWTH BY TARGETING SMARCA5 AND ERBB3 IN GBM STEM-LIKE CELLS VIA TWO DISTINCT TRANSCRIPTS Neuro-Oncology. 18: vi81-vi81. DOI: 10.1093/Neuonc/Now212.341  0.278
2009 Lang BT, Yan Y, Dempsey RJ, Vemuganti R. Impaired neurogenesis in adult type-2 diabetic rats. Brain Research. 1258: 25-33. PMID 19138677 DOI: 10.1016/J.Brainres.2008.12.026  0.277
2017 Lopez MS, Dempsey RJ, Vemuganti R. The microRNA miR-21 conditions the brain to protect against ischemic and traumatic injuries. Conditioning Medicine. 1: 35-46. PMID 34268484  0.276
2007 Kalluri HS, Vemuganti R, Dempsey RJ. Mechanism of insulin-like growth factor I-mediated proliferation of adult neural progenitor cells: role of Akt. The European Journal of Neuroscience. 25: 1041-8. PMID 17331200 DOI: 10.1111/J.1460-9568.2007.05336.X  0.27
2021 Vemuganti R, Arumugam TV. Much ado about eating: Intermittent fasting and post-stroke neuroprotection. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211009362. PMID 33853407 DOI: 10.1177/0271678X211009362  0.269
2015 Schomberg D, Miranpuri G, Duellman T, Crowell A, Vemuganti R, Resnick D. Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches. Metabolic Brain Disease. 30: 645-58. PMID 25588751 DOI: 10.1007/S11011-014-9642-0  0.266
2018 Mehta SL, Vemuganti R. Ischemic Stroke Alters the Expression of the Transcribed Ultraconserved Regions of the Genome in Rat Brain. Stroke. 49: 1024-1028. PMID 29581345 DOI: 10.1161/STROKEAHA.118.020663  0.264
2008 Yan YP, Vemuganti R, Dempsey RJ. Post-ischemic neurogenesis and brain repair: Growth factors and cytokines Experimental Stroke. 74-82. DOI: 10.2174/978160805001710901010074  0.263
2023 Chelluboina B, Jeong S, Davis CK, Mehta SL, Vemuganti R. Therapeutic Potential of Intravenous miR-21 Mimic after Stroke Following STAIR Criteria. Translational Stroke Research. PMID 38129636 DOI: 10.1007/s12975-023-01223-8  0.262
2006 DomBourian MG, Turner NA, Gerovac TA, Vemuganti R, Miranpuri GS, Türeyen K, Satriotomo I, Miletic V, Resnick DK. B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury. Spine. 31: 2778-82. PMID 17108828 DOI: 10.1097/01.Brs.0000245865.97424.B4  0.261
2022 Davis CK, Bathula S, Hsu M, Morris-Blanco KC, Chokkalla AK, Jeong S, Choi J, Subramanian S, Park JS, Fabry Z, Vemuganti R. An antioxidant and anti-ER stress combo therapy decreases inflammation, secondary brain damage and promotes neurological recovery following traumatic brain injury in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 35882557 DOI: 10.1523/JNEUROSCI.0212-22.2022  0.255
2011 Bowen KK, Dempsey RJ, Vemuganti R. Adult interleukin-6 knockout mice show compromised neurogenesis. Neuroreport. 22: 126-30. PMID 21266900 DOI: 10.1097/Wnr.0B013E3283430A44  0.254
2005 Kalluri HS, Vemuganti R, Dempsey RJ. Lack of response to epidermal growth factor in adult neural progenitor cells. Neuroreport. 16: 835-8. PMID 15891580 DOI: 10.1097/00001756-200505310-00011  0.252
2017 Chandran R, Kim T, Mehta SL, Udho E, Chanana V, Cengiz P, Kim H, Kim C, Vemuganti R. A combination antioxidant therapy to inhibit NOX2 and activate Nrf2 decreases secondary brain damage and improves functional recovery after traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17738701. PMID 29083257 DOI: 10.1177/0271678X17738701  0.251
2021 Chandran R, Mehta SL, Vemuganti R. Antioxidant Combo Therapy Protects White Matter After Traumatic Brain Injury. Neuromolecular Medicine. PMID 33486699 DOI: 10.1007/s12017-021-08645-3  0.25
2021 Mehta SL, Chokkalla AK, Vemuganti R. Noncoding RNA crosstalk in brain health and diseases. Neurochemistry International. 149: 105139. PMID 34280469 DOI: 10.1016/j.neuint.2021.105139  0.248
2019 Chelluboina B, Vemuganti R. Chronic kidney disease in the pathogenesis of acute ischemic stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19866733. PMID 31366298 DOI: 10.1177/0271678X19866733  0.246
2010 Vemuganti R. New therapeutic targets for neuroprotection against acute brain injuries Open Drug Discovery Journal. 2: 107.  0.238
2022 Ng GY, Sheng DPLK, Bae HG, Kang SW, Fann DY, Park J, Kim J, Alli-Shaik A, Lee J, Kim E, Park S, Han JW, Karamyan V, Okun E, Dheen T, ... ... Vemuganti R, et al. Integrative epigenomic and transcriptomic analyses reveal metabolic switching by intermittent fasting in brain. Geroscience. PMID 35357643 DOI: 10.1007/s11357-022-00537-z  0.235
2020 Chelluboina B, Kim T, Mehta SL, Kim JY, Bathula S, Vemuganti R. Impact of Age and Sex on α-Syn (α-Synuclein) Knockdown-Mediated Poststroke Recovery. Stroke. STROKEAHA120028978. PMID 32819195 DOI: 10.1161/STROKEAHA.120.028978  0.233
2018 Rao Nalamolu K, Smith NJ, Chelluboina B, Klopfenstein JD, Pinson DM, Wang DZ, Vemuganti R, Kumar Veeravalli K. Prevention of the severity of post-ischemic inflammation and brain damage by simultaneous knockdown of toll-like receptors 2 and 4. Neuroscience. PMID 29337240 DOI: 10.1016/j.neuroscience.2018.01.014  0.232
2016 Cikla U, Chanana V, Kintner DB, Udho E, Eickhoff J, Sun W, Marquez S, Covert L, Otles A, Shapiro RA, Ferrazzano P, Vemuganti R, Levine JE, Cengiz P. ERα Signaling Is Required for TrkB-Mediated Hippocampal Neuroprotection in Female Neonatal Mice after Hypoxic Ischemic Encephalopathy(1,2,3). Eneuro. 3. PMID 26839918 DOI: 10.1523/ENEURO.0025-15.2015  0.231
2019 Vemuganti R. Stroke: Molecular Mechanisms and Therapies. Neuromolecular Medicine. PMID 31745713 DOI: 10.1007/s12017-019-08580-4  0.227
2017 Vemuganti R, Hall ED. Cellular and molecular mechanisms of neuroprotection and plasticity after traumatic brain injury. Neurochemistry International. PMID 28964776 DOI: 10.1016/J.Neuint.2017.09.014  0.225
2022 Mehta SL, Kim T, Chelluboina B, Vemuganti R. Tau and GSK-3β are Critical Contributors to α-Synuclein-Mediated Post-Stroke Brain Damage. Neuromolecular Medicine. PMID 36447045 DOI: 10.1007/s12017-022-08731-0  0.217
2022 Mehta SL, Chokkalla AK, Bathula S, Vemuganti R. MicroRNA miR-7 Is Essential for Post-stroke Functional Recovery. Translational Stroke Research. PMID 35088373 DOI: 10.1007/s12975-021-00981-7  0.208
2008 Rizk EB, Meier B, Unlu A, Iskandar B, Medow JE, Moftakhar R, Hariharan N, Vemuganti R, Sun D. The Na+, K+-ATPase Pump is Essential for Regeneration of the Injured Adult Central Nervous System Neurosurgery. 62: 1410. DOI: 10.1227/01.Neu.0000333484.33571.28  0.206
2005 Vemuganti R. Colloquium C12: Transcriptional mechanisms of cerebral inflammation Journal of Neurochemistry. 94: 116-117. DOI: 10.1111/j.1474-1644.2005.03231_4.x  0.2
2022 Davis CK, Vemuganti R. Antioxidant therapies in traumatic brain injury. Neurochemistry International. 152: 105255. PMID 34915062 DOI: 10.1016/j.neuint.2021.105255  0.194
2020 Davis CK, Vemuganti R. DNA damage and repair following traumatic brain injury. Neurobiology of Disease. 147: 105143. PMID 33127471 DOI: 10.1016/j.nbd.2020.105143  0.15
2021 Yin KJ, Vemuganti R. Long noncoding RNAs and CNS disorders. Neurochemistry International. 105176. PMID 34481038 DOI: 10.1016/j.neuint.2021.105176  0.13
2020 Vemuganti R, Arumugam TV. Molecular Mechanisms of Intermittent Fasting-induced Ischemic Tolerance. Conditioning Medicine. 3: 9-17. PMID 34278242  0.128
2024 Davis CK, Arruri V, Joshi P, Vemuganti R. Non-pharmacological interventions for traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X241234770. PMID 38388365 DOI: 10.1177/0271678X241234770  0.12
2015 Dharap A, Pokrzywa C, Murali S, Kaimal B, Vemuganti R. Mutual induction of transcription factor PPARγ and microRNAs miR-145 and miR-329 Journal of Neurochemistry. DOI: 10.1111/jnc.13220  0.114
2021 Vemuganti R, Shah Z. Oxidative stress in chronic and acute CNS insults. Neurochemistry International. 153: 105274. PMID 34971748 DOI: 10.1016/j.neuint.2021.105274  0.1
2007 Adlakha VG, Vemuganti RR. The effect of data scaling on dual prices and sensitivity analysis in linear programs International Journal of Mathematical Education in Science and Technology. 38: 708-713. DOI: 10.1080/00207390701368777  0.022
1968 Smith BE, Vemuganti RR. A Learning Model for Processes with Tool Wear Technometrics. 10: 379-387. DOI: 10.1080/00401706.1968.10490569  0.016
2007 Adlakha V, Kowalski K, Vemuganti RR, Lev B. More-for-less algorithm for fixed-charge transportation problems Omega. 35: 116-127. DOI: 10.1016/j.omega.2006.03.001  0.01
2004 Vemuganti RR. On gradient simplex methods for linear programs Journal of Applied Mathematics and Decision Sciences. 8: 107-129.  0.01
1995 Aggarwal AK, Oblak M, Vemuganti RR. A heuristic solution procedure for multicommodity integer flows Computers and Operations Research. 22: 1075-1087. DOI: 10.1016/0305-0548(94)00085-M  0.01
1990 Vemuganti RR, Dianich D, Oblak M, Dabbaghi H. Constrained optimal production lot sizes for several products American Journal of Mathematical and Management Sciences. 10: 199-228. DOI: 10.1080/01966324.1990.10737283  0.01
1989 Vemuganti RR, Arsham H, Shao SP. An implementation of Lagrangian decomposition in solving a multi-item production scheduling problem with changeover cost and restrictions Mathematical and Computer Modelling. 12: 1437-1446. DOI: 10.1016/0895-7177(89)90321-X  0.01
1987 Vemuganti RR. MAXIMUM VALUE OF INVENTORY AND SHORTAGES IN PRODUCTION LOT SIZE SYSTEMS. Iie Transactions (Institute of Industrial Engineers). 19: 404-411. DOI: 10.1080/07408178708975413  0.01
1978 Vemuganti RR. ON THE FEASIBILITY OF SCHEDULING LOT SIZES FOR TWO PRODUCTS ON ONE MACHINE. Manage Sci. 24: 1668-1673.  0.01
1978 Love RR, Vemuganti RR. SINGLE-PLANT MOLD ALLOCATION PROBLEM WITH CAPACITY AND CHANGEOVER RESTRICTIONS. Operations Research. 26: 159-165.  0.01
1977 Aneja YP, Vemuganti RR. ROW GENERATION SCHEME FOR FINDING A MULTI-COMMODITY MINIMUM DISCONNECTING SET. Management Science. 23: 652-659.  0.01
Hide low-probability matches.